These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15585924)

  • 1. Immunotherapy with CTL restricted by nonself MHC.
    Gao L; Downs AM; Stauss HJ
    Methods Mol Med; 2005; 109():215-28. PubMed ID: 15585924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy.
    Sadovnikova E; Stauss HJ
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13114-8. PubMed ID: 8917553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathymic selection: new insight into tumor immunology.
    Kazansky DB
    Adv Exp Med Biol; 2007; 601():133-44. PubMed ID: 17713000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
    Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
    Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the frequency of peptide-specific cytotoxic T lymphocytes restricted by self- and allo-MHC following in vitro T cell priming.
    Yang TH; Lovatt M; Merkenschlager M; Stauss HJ
    Int Immunol; 2002 Nov; 14(11):1283-90. PubMed ID: 12407019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
    Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man.
    Lotz C; Ferreira EA; Drexler I; Mutallib SA; Huber C; Sutter G; Theobald M
    Int J Cancer; 2004 Feb; 108(4):571-9. PubMed ID: 14696122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed protein.
    Dahl AM; Beverley PC; Stauss HJ
    J Immunol; 1996 Jul; 157(1):239-46. PubMed ID: 8683121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of high avidity CTL by altering the balance of signals from APC.
    Oh S; Hodge JW; Ahlers JD; Burke DS; Schlom J; Berzofsky JA
    J Immunol; 2003 Mar; 170(5):2523-30. PubMed ID: 12594278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
    Jäger E; Chen YT; Drijfhout JW; Karbach J; Ringhoffer M; Jäger D; Arand M; Wada H; Noguchi Y; Stockert E; Old LJ; Knuth A
    J Exp Med; 1998 Jan; 187(2):265-70. PubMed ID: 9432985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting p53, hdm2, and CD19: vaccination and immunologic strategies.
    Voss RH; Lotz C; Cellary A; Theobald M
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S43-5. PubMed ID: 10933187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes.
    Roopenian DC; Davis AP
    Immunogenetics; 1989; 30(5):335-43. PubMed ID: 2530167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides.
    Melief CJ; Kast WM
    Ciba Found Symp; 1994; 187():97-104; discussion 104-12. PubMed ID: 7796678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune recognition of human T-cell leukemia virus type-I (HTLV-I) by MHC-restricted cytotoxic T lymphocytes.
    Tanaka Y
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):79-85. PubMed ID: 1308259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
    Bertholet S; Iggo R; Corradin G
    Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
    Maziarz R; Allen H; Strominger JL; Flavell R; Biro PA; Burakoff SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6276-80. PubMed ID: 3875858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.